The role of ARG2 in pancreatic cancer was suggested by Zaytouni et al., who observed that the silencing or loss of Arg2 suppresses obesity-driven pancreatic cancer development [127]. This evidence concerns the gene ARG2 and obesity due to melanocortin 4 receptor deficiency.